Stem Cell Research and News: Israel
<-- Back To RegionsHeart Muscle With Built-In Blood Supply Created From Stem Cells
Researchers at the Technion-Israel Institute of Technology have created new heart muscle with its own blood supply using human embryonic stem cells. The newly engineered muscle could replace cardiac tissue damaged in heart attacks. Researchers' study was published online January...
Posted in Today's Stem Cell Research on January 31, 2007 09:21 PM
Stem Cell Research Findings For Wider Applications
British Journal of Haematology published research data which demonstrates that a patient's own blood has the capacity to help in the regeneration and repair of a multitude of damaged tissues. The efficacy of adult stem cell treatment for cardiac patients...
Posted in Today's Stem Cell Research on November 9, 2006 07:15 AM
Stem Cell Research To Help Athletes' Tendons and Ligaments
A new approach for tendon regeneration is is being announced in the April issue of the Journal of Clinical Investigation. Stem cell Researchers Prof. Dan Gazit is leading a team at the Skeletal Biotechnology Laboratory at the Hebrew University Faculty...
Posted in Today's Stem Cell Research on April 6, 2006 01:08 PM
Cord Blood Collection Company Biocord Ltd Seeking Capital
Cord blood as we all know is one of the hot "controversy free" methods of collecting umbilical cord stem cells for both research and a growing variety of stem cell therapies. Biocord Ltd. has entered the growing number of cord...
Posted in Today's Stem Cell Research on February 28, 2006 06:52 PM
Stem Cell Heart Procedures Getting Feedback
In the stem cell research field, we generally read mainly pure research articles, as so much out there is still in development. However, there are have been some studies abroad that are showing results. With all the controversy with researchers...
Posted in Today's Stem Cell Research on February 14, 2006 03:09 PM
Stem Cell Cure for Peripheral Vascular Disease on the Horizon
Bangkok - TheraVitae, Ltd has announced its intention to begin clinical trials using autologous adult stem cells to treat patients suffering from Peripheral Vascular Disease (PVD). The trials are slated for November 2005 and will be held in conjunction with...
Posted in Today's Stem Cell Research on November 4, 2005 01:03 PM
New Life Scientific, Inc. and UTEK Corporation Announce Strategic Alliance Agreement
FREEHOLD, N.J. and PLANT CITY, Fla. - Sept. 22, 2005 - New Life Scientific, Inc. (OTCBB:NWLF), a company engaged in developing stem cell banks and stem cell treatment facilities, and UTEK Corporation (AMEX:UTK) (LSE-AIM:UTKA), an innovative technology transfer company, announced...
Posted in Today's Stem Cell Research on October 4, 2005 05:58 PM
Californian Heart Disease Patient Shows Improvement After Stem Cell Therapy
Improvement of California woman stuns her cardiologist one month after receiving stem cell treatment in Bangkok, Thailand. Palo Verde, CA (PRWEB) September 9, 2005 - Dee Coats, the first Californian to receive VesCell™ stem cell therapy for heart disease is...
Posted in Today's Stem Cell Research on September 22, 2005 03:55 PM
France Approves Importation of Stem Cell Lines
France has approved, with certain restrictions, the importing of stem cell lines for stem cell research development. Nine ministerial orders were published in France's official journal on July 23, 2005 give a restricted licence to a number of national research...
Posted in Today's Stem Cell Research on August 1, 2005 05:38 PM
Researchers Find Circulating Stem Cells Play Role in Lung Repair
HOUSTON, TEXAS — (July 27, 2005)— Circulating stem cells play a minor role in repairing lung damage, according to a team of scientists who used male and female chromosomal differences to analyze the repair process in lung transplant patients. Reporting...
Posted in Today's Stem Cell Research on July 28, 2005 10:09 AM
StemCyte, Inc. Completes Significant Round of Financing
Leader in Stem Cell Technology Adds New Investors ARCADIA, Calif., July 19 /PRNewswire/ - StemCyte®, Inc., a leading umbilical cord blood stem cell transplantation and therapeutic products company, today announced it has recently completed a significant round of financing from...
Posted in Today's Stem Cell Research on July 26, 2005 01:55 PM
Victoria Launches New Human Embryonic Stem Cell Line & Drives International Stem Cell Network
MELBOURNE, Australia and PHILADELPHIA, June 19 -- A second human embryonic stem cell line to be made available to researchers worldwide without commercial or intellectual property restraints was announced by the Victorian Premier, Steve Bracks, at the global biotechnology conference...
Posted in Today's Stem Cell Research on June 19, 2005 11:34 AM
US Heart Patients Being Treated with Adult Stem Cells in Thailand
In Thailand, Chaophya Hospital is now treating no-option heart disease patients from abroad with adult stem cell therapy developed by TheraVitae Ltd. Dr. Amit Patel M.D., Director of Cardiac Stem Cell Therapies at The McGowan Institute for Regenerative Medicine, University...
Posted in Today's Stem Cell Research on June 2, 2005 04:52 PM
BrainStorm Cell Therapeutics, Appoints Renowned Neurologists Prof. Warren Olanow and Prof. Andre Lozano to Scientific Advisory Board
NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--April 27, 2005--BrainStorm Cell Therapeutics (OTCBB:BCLI), an emerging company in stem cell therapeutics for neurological diseases, today announced that Prof. Andre Lozano and Prof. C. Warren Olanow, internationally renowned clinical neurologists and researchers, have...
Posted in Today's Stem Cell Research on May 3, 2005 12:36 PM
PharmaFrontiers Announces Dr. Eliezer Huberman to Chair Scientific Advisory Board
THE WOODLANDS, Texas--(BUSINESS WIRE)--April 26, 2005--PharmaFrontiers Corp. (OTCBB:PFTR), a company involved in the development and commercialization of cell therapies, announced today that Dr. Eliezer Huberman, Ph.D., an authority in the area of adult pluripotent stem cell technology, has agreed to...
Posted in Today's Stem Cell Research on May 1, 2005 11:41 AM
Israel's Consortium Bereshit for Cell Therapy
Israel's $15-20 million stem cell project was created under the authority of the Chief Scientist's Office of the Ministry of Industry and Trade. The consortium is composed of some of Israel's leading stem cell researchers. Several Israeli companies participate in...
Posted in Today's Stem Cell Research on April 25, 2005 04:55 PM
Stem Cell Research Breakthrough in Australia
A new way of extracting stem cells from embryonic stem cells has been developed in Australia that may ultimately lead to new treatments for diabetes and Parkinson's disease, scientists said on Wednesday. Seen as an Australian first, the breakthrough puts...
Posted in Today's Stem Cell Research on April 13, 2005 03:42 PM
BrainStorm Cell Therapeutics Appoints Dr. Robert Shorr to the Board of Directors; Renowned Scientist, Entrepreneur and Business Development Veteran to Add Significant Value in Creating Alliances, Financing And Development
TEL AVIV, Israel-(BUSINESS WIRE)-March 31, 2005-BrainStorm Cell Therapeutics (OTC BB: BCLI.OB), an emerging company in stem cell therapeutics for neurodegenerative diseases, today announced that Dr. Robert G.L. Shorr was appointed to the Board of Directors. Dr. Shorr has great stature...
Posted in Today's Stem Cell Research on March 31, 2005 06:55 PM
BrainStorm Appoints Prof. Jeffrey Kordower to its Scientific Advisory Board; World Renowned Neurologist and Specialist in Gene and Neural Transplantation to Provide Company Invaluable Guidance
TEL AVIV, Israel - BrainStorm Cell Therapeutics (OTCBB:BCLI), an emerging company in stem cell therapeutics for neurological diseases, today announced that Prof. Jeffrey Kordower, globally renowned neurologist scientist has joined the Company's Scientific Advisory Board, bringing a wealth of experience...
Posted in Today's Stem Cell Research on March 31, 2005 05:53 PM
Brainstorm Cell Therapeutics Developing Parkinson's Treatment
Brainstorm Cell Therapeutics is currently developing a new stem cell therapy specifically to treat Parkinson's Disease. The research includes using a patient's bone marrow stem cells to produce the missing chemical that enables restoration of motor movement. This process has...
Posted in Today's Stem Cell Research on March 31, 2005 12:13 PM
More Push for Stem Cell Research Funding in New York
Scientists from New York area universities and biotech companies joined with local activist Brooke Ellison and Rep. Steven Israel (D-Huntington) yesterday to demand that New York approve funding for medical research using embryonic stem cells. Througough this month, legislation has...
Posted in Today's Stem Cell Research on March 25, 2005 05:54 PM
BrainStorm Appoints Prof. Ole Isacson to Scientific Advisory Board; Award Winning Neurologist and Advisor to Michael J. Fox Foundation to Provide Compelling Research Direction
TEL AVIV, Israel--(BUSINESS WIRE)--Mar 24, 2005 - BrainStorm Cell Therapeutics (OTCBB:BCLI), an emerging company in stem cell therapeutics for neurological diseases, today announced that Prof. Ole Isacson, internationally renowned neurologist and pioneering innovator in cell therapeutic strategies for neural regeneration,...
Posted in Today's Stem Cell Research on March 24, 2005 06:36 PM
Pluristem Obtains Notice of Allowance from U.S. Patent Office Providing Broad Coverage of Proprietary Stem Cell Expansion Technology
HAIFA, Israel--(BUSINESS WIRE)--Mar 24, 2005 - Pluristem Life Systems, Inc. (OTC BB: PLRS), a biotechnology company dedicated to the expansion of stem cells from umbilical cord blood to address a myriad of fatal illnesses, today announced that it received a...
Posted in Today's Stem Cell Research on March 24, 2005 06:23 PM
Massachusetts Poll Shows Residents Support Stem Cell Research
Lobbying for stem cell research increase in pitch on Beacon Hill with yet another poll showing overwhelming support for such research and further a coalition of more than 20 advocacy groups, scientists and researchers launching their campaign in support. This...
Posted in Today's Stem Cell Research on March 24, 2005 04:37 PM
$6M Donated By Florida Couple for Stem Cell Research
A prominent Bay State developer and his wife are giving $6 million to a Hub hospital specifically for stem cell research. This is one of the largest ever donations given to the Beth Israel Deaconess Medical Center. The donation, which...
Posted in Today's Stem Cell Research on March 14, 2005 12:31 PM
Stem Cells Promoting Xenotransplant Research
Israeli scientists are now researching the use stem cells from pig embryos to grow replacement organs for transplantation. Thusfar these organs have grown and functioned well in mice... Transplant surgeons have long been dreaming of using animals to make up...
Posted in Today's Stem Cell Research on March 10, 2005 11:30 AM
Pluristem Completes $3.2 Million Interim Private Placement
HAIFA, Israel--(BUSINESS WIRE)--Mar 7, 2005-- Pluristem Life Systems, Inc. (OTCBB: PLRS), a biotechnology company dedicated to the expansion of stem cells from umbilical cord blood to address a myriad of fatal illnesses, today announced that the Company completed private placements...
Posted in Today's Stem Cell Research on March 7, 2005 08:28 PM
US Patent Office Rejects PharmaStem Cord Blood Stem Cell Patents
ThermoGenesis Corp. (Nasdaq: KOOL), a supplier of cryogenic devices used by cord blood banks, and NETCORD, the leading international network of public cord blood banks, today announced that the U.S. Patent Office (PTO) has reexamined U.S. Patent 5,192,553 (Patent '553)...
Posted in Today's Stem Cell Research on March 1, 2005 07:47 PM
BrainStorm Cell Therapeutics Launches into Next Phase with the Lease of New R&D Facility and Office Space
BrainStorm Cell Therapeutics Ltd. (BrainStorm), the Israeli subsidiary of BrainStorm Cell Therapeutics Inc. (OTC Bulletin Board: BCLI), an emerging company in the cell therapy space, has announced that it has leased new space in Kiryat Ha'Mada Ve Ha'Technologia in Petach...
Posted in Today's Stem Cell Research on February 22, 2005 01:50 PM
Teva to Commercialize Gamida-Cell's StemEx
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) and Gamida-Cell Ltd. have announced that Teva has exercised the option to enter into a joint venture with Gamida-Cell Ltd. The two companies will develop and commercialize Gamida-Cell's StemEx for the treatment...
Posted in Today's Stem Cell Research on February 17, 2005 03:48 PM
Israel: Replacement Organs Could Come from Pig Embryos
Pig embryos could provide sources of new organ and tissue transplants for people, and they may pose fewer risks than using material from adult animals, Israeli researchers reported on Monday. They found that if cells were taken from pig embryos...
Posted in Today's Stem Cell Research on February 15, 2005 03:42 AM
Collaborative Stem Cell Research Program Announced
The Coriell Institute for Medical Research and the Technion-Israel Institute of Technology said Thursday they are creating a collaborative program to advance the study of adult and embryonic stem cells. A pledge of $1 million from Coriell trustee Ed Satell...
Posted in Today's Stem Cell Research on February 7, 2005 10:25 AM
Pluristem Life Systems, Inc. (PLRS) Corp. Sheet
Pluristem Life Systems, Inc. Articles More Pluristem Life Systems, Inc. Articles Corporate Summary (site quote): Pluristem Ltd. was founded by Dr. Shai Meretzki and others following five years of research and development at the Technion Israel Institute of Technology...
Posted in Today's Stem Cell Research on January 24, 2005 06:38 PM
BrainStorm Cell Therapeutics, Inc. (BCLI.OB) Corp. Sheet
BrainStorm Cell Therapeutics, Inc. Articles More BrainStorm Cell Therapeutics, Inc. Articles Corporate Summary (site quote): BrainsStorm Cell Therapeutics LTD. is an Israeli subsidiary of BrainStorm Cell Therapeutics Inc., an emerging company developing neural-like cells derived from bone marrow for...
Posted in Today's Stem Cell Research on January 21, 2005 01:52 PM
Israeli Gamida-Cell enters Phase III for Leukemia treatment
"Ten leukemia patients, many of whom had failed standard chemotherapy and other therapies, underwent StemEx(R) transplants. StemEx(R) combines ex vivo expanded cord blood stem/progenitor cells with non-expanded cells from the same unit. The net results of the Phase I/II study...
Posted in Today's Stem Cell Research on December 9, 2004 07:38 AM